
Sign up to save your podcasts
Or
đ Bright Minds Bio is a psychedelics research company focused on novel  psychedelics with shorter trip times and lower risk than traditional  psychedelics.  In this episode of The Integration Conversation, we  discuss the risk of traditional psychedelics, what a 5HT2C agonist is,  Bright Mind's NASDAQ Uplisting, and discuss why Bright Minds might be  undervalued relative to its peers.    Â
âď¸ Become an Integration Insider and get early access to episodes:Â
https://patreon.com/theintegrationco Â
đ§ Listen on Spotify and other podcast platforms: Â
https://anchor.fm/theintegrationco Â
đŚ brom on twitter: Â
https://twitter.com/therealbrom Â
đ Clips and other stuff on Instagram: Â
https://instagram.com/theintegrationco Â
đ Email: Â Â
â° Timestamps: Â
Disclaimer: This video is not financial advice. Brom holds shares in Bright Minds.
5
66 ratings
đ Bright Minds Bio is a psychedelics research company focused on novel  psychedelics with shorter trip times and lower risk than traditional  psychedelics.  In this episode of The Integration Conversation, we  discuss the risk of traditional psychedelics, what a 5HT2C agonist is,  Bright Mind's NASDAQ Uplisting, and discuss why Bright Minds might be  undervalued relative to its peers.    Â
âď¸ Become an Integration Insider and get early access to episodes:Â
https://patreon.com/theintegrationco Â
đ§ Listen on Spotify and other podcast platforms: Â
https://anchor.fm/theintegrationco Â
đŚ brom on twitter: Â
https://twitter.com/therealbrom Â
đ Clips and other stuff on Instagram: Â
https://instagram.com/theintegrationco Â
đ Email: Â Â
â° Timestamps: Â
Disclaimer: This video is not financial advice. Brom holds shares in Bright Minds.
32,073 Listeners
225,496 Listeners
1,795 Listeners
9,265 Listeners
2,287 Listeners
110,824 Listeners
298 Listeners
2,619 Listeners
5,361 Listeners
9,216 Listeners
424 Listeners
51 Listeners
5,437 Listeners
15,363 Listeners
8,560 Listeners